167 related articles for article (PubMed ID: 22593767)
1. Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells.
Liu Y; Burkhalter R; Symowicz J; Chaffin K; Ellerbroek S; Stack MS
J Oncol; 2012; 2012():501492. PubMed ID: 22593767
[TBL] [Abstract][Full Text] [Related]
2. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Symowicz J; Adley BP; Gleason KJ; Johnson JJ; Ghosh S; Fishman DA; Hudson LG; Stack MS
Cancer Res; 2007 Mar; 67(5):2030-9. PubMed ID: 17332331
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
Gil OD; Lee C; Ariztia EV; Wang FQ; Smith PJ; Hope JM; Fishman DA
Gynecol Oncol; 2008 Feb; 108(2):361-9. PubMed ID: 18073130
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination.
Klymenko Y; Bos B; Campbell L; Loughran E; Liu Y; Yang J; Kim O; Stack MS
Sci Rep; 2020 Jul; 10(1):10877. PubMed ID: 32616784
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.
He D; Su Y; Usatyuk PV; Spannhake EW; Kogut P; Solway J; Natarajan V; Zhao Y
J Biol Chem; 2009 Sep; 284(36):24123-32. PubMed ID: 19586906
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Cowden Dahl KD; Symowicz J; Ning Y; Gutierrez E; Fishman DA; Adley BP; Stack MS; Hudson LG
Cancer Res; 2008 Jun; 68(12):4606-13. PubMed ID: 18559505
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
Burkhalter RJ; Westfall SD; Liu Y; Stack MS
J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
[TBL] [Abstract][Full Text] [Related]
8. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions.
Usui A; Ko SY; Barengo N; Naora H
Mol Cancer Res; 2014 Apr; 12(4):504-13. PubMed ID: 24448686
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Do TV; Symowicz JC; Berman DM; Liotta LA; Petricoin EF; Stack MS; Fishman DA
Mol Cancer Res; 2007 Feb; 5(2):121-31. PubMed ID: 17314270
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J; Adley BP; Woo MM; Auersperg N; Hudson LG; Stack MS
Cancer Res; 2005 Mar; 65(6):2234-42. PubMed ID: 15781636
[TBL] [Abstract][Full Text] [Related]
11. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2).
So J; Wang FQ; Navari J; Schreher J; Fishman DA
Gynecol Oncol; 2005 Jun; 97(3):870-8. PubMed ID: 15919106
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
Fishman DA; Liu Y; Ellerbroek SM; Stack MS
Cancer Res; 2001 Apr; 61(7):3194-9. PubMed ID: 11306508
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid modulates the association of PTP1B with N-cadherin/catenin complex in SKOV3 ovarian cancer cells.
Huang RY; Wen CC; Liao CK; Wang SH; Chou LY; Wu JC
Cell Biol Int; 2012 Sep; 36(9):833-41. PubMed ID: 22582758
[TBL] [Abstract][Full Text] [Related]
15. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.
Said NA; Najwer I; Socha MJ; Fulton DJ; Mok SC; Motamed K
Neoplasia; 2007 Jan; 9(1):23-35. PubMed ID: 17325741
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression.
Hudson LG; Zeineldin R; Stack MS
Clin Exp Metastasis; 2008; 25(6):643-55. PubMed ID: 18398687
[TBL] [Abstract][Full Text] [Related]
17. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.
Klymenko Y; Johnson J; Bos B; Lombard R; Campbell L; Loughran E; Stack MS
Neoplasia; 2017 Jul; 19(7):549-563. PubMed ID: 28601643
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of BMP signalling abrogates experimental metastasis of OVCA429 cells via reduced cell adhesion.
Shepherd TG; Mujoomdar ML; Nachtigal MW
J Ovarian Res; 2010 Feb; 3():5. PubMed ID: 20187934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]